Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11601
Oramed Pharmaceuticals
ORMP
$212M
| $74.1K | ﹤0.01% |
25,984
-10,841
| -29% | -$28K |
|
11602
CALL
Full House Resorts
FLL
$75.5M
| $73.9K | ﹤0.01% |
28,300
-18,800
| -40% | -$50.5K |
|
11603
PUT
Alpha Pro Tech
APT
$55.8M
| $73.7K | ﹤0.01% |
16,600
-51,200
| -76% | -$236K |
|
|
BHR
11604
Braemar Hotels & Resorts
BHR
$142M
| $73.5K | ﹤0.01% |
+25,610
| New | +$69K |
|
|
RC
11605
PUT
Ready Capital
RC
$306M
| $73.5K | ﹤0.01% |
33,700
-117,300
| -78% | -$329K |
|
11606
LGL Group
LGL
$93M
| $73.4K | ﹤0.01% |
+12,764
| New | +$77.4K |
|
11607
Digital Turbine
APPS
$1.38B
| $73.2K | ﹤0.01% |
14,647
-1,531
| -9% | -$8.66K |
|
11608
PUT
American Well
AMWL
$200M
| $73.2K | ﹤0.01% |
+14,900
| New | +$71.8K |
|
|
CD
11609
CALL
Chaince Digital Holdings
CD
$376M
| $72.6K | ﹤0.01% |
14,600
-6,200
| -30% | -$71.8K |
|
11610
CALL
Lifestance Health
LFST
$4.7B
| $72.5K | ﹤0.01% |
10,300
-38,600
| -79% | -$233K |
|
11611
PUT
Protara Therapeutics
TARA
$236M
| $72.5K | ﹤0.01% |
+13,600
| New | +$75.6K |
|
11612
PUT
Black Diamond Therapeutics
BDTX
$130M
| $72.4K | ﹤0.01% |
+29,800
| New | +$106K |
|
11613
PUT
StealthGas
GASS
$353M
| $72.3K | ﹤0.01% |
+10,300
| New | +$69.2K |
|
|
SVC
11614
Service Properties Trust
SVC
$989M
| $72.2K | ﹤0.01% |
7,847
-74,233
| -90% | -$746K |
|
|
ACRE
11615
PUT
Ares Commercial Real Estate
ACRE
$257M
| $72.2K | ﹤0.01% |
15,100
-23,700
| -61% | -$115K |
|
11616
TOP Financial Group
TOP
$1.91B
| $71.9K | ﹤0.01% |
14,373
+4,014
| +39% | +$23K |
|
11617
CALL
VinFast Auto
VFS
$7.37B
| $71.8K | ﹤0.01% |
21,500
-54,500
| -72% | -$182K |
|
11618
CALL
Editas Medicine
EDIT
$507M
| $71.8K | ﹤0.01% |
35,000
-44,200
| -56% | -$128K |
|
|
FIGG
11619
Leverage Shares 2x Long FIG Daily ETF
FIGG
$19.2M
| $71.7K | ﹤0.01% |
+785
| New | +$103K |
|
11620
ADC Therapeutics
ADCT
$143M
| $71.2K | ﹤0.01% |
+20,178
| New | +$81.9K |
|
11621
PUT
Inovio Pharmaceuticals
INO
$130M
| $71K | ﹤0.01% |
40,800
+18,000
| +79% | +$39.6K |
|
11622
CALL
Tenaya Therapeutics
TNYA
$156M
| $70.9K | ﹤0.01% |
99,900
-50,900
| -34% | -$69.2K |
|
|
AIOT
11623
PowerFleet Inc
AIOT
$403M
| $70.9K | ﹤0.01% |
13,331
-235,287
| -95% | -$1.2M |
|
11624
PUT
C4 Therapeutics
CCCC
$504M
| $70.9K | ﹤0.01% |
37,100
-94,300
| -72% | -$223K |
|
11625
OraSure Technologies
OSUR
$254M
| $70.7K | ﹤0.01% |
29,215
+3,462
| +13% | +$9.1K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.